Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Kshitij Agarwal (New Delhi, India), Kshitij Agarwal, Anuradha Chowdhary, M. Rahman, Anil Chaudhry, S.N. Gaur. Risk factors and treatment outcomes in patients with chronic pulmonary aspergillosis. Eur Respir J 2016; 48: Suppl. 60, 2647

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for chronic pulmonary aspergillosis in a low prevalence country and their effect on survival Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Factors contributing to severe pneumonia in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Risk of pneumonia in chronic obstructive pulmonary disease patients treated with inhaled corticosteroids. Results from the OUTPUL study Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Burden and impact of hospital-acquired infections in patients with chronic lung disease Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption Year: 2016 Source of referral and other factors affecting readmission for patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Clinical characteristics and prognosis of chronic pulmonary aspergillosis Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes? Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Assessment of patients preferences regarding characteristics associated with treatment of chronic obstructive pulmonary disease Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Pulmonary nocardiosis (PN) complicating chronic pulmonary diseases Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Mortality and survival predictor in chronic hypersensitivity pneumonitis Source: International Congress 2016 – Sarcoidosis Year: 2016 Treatment and prevention of acute respiratory viral infections in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Viral infections Year: 2013 Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis Source: Eur Respir J, 58 (2) 2003345; 10.1183/13993003.03345-2020 Year: 2021 Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Recurrent exacerbation of asthma: Characteristics of the patients and risk factors Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Risk factors for chronic obstructive pulmonary disease in women Source: Eur Respir J 2002; 20: Suppl. 38, 326s Year: 2002 Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseases Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Interferon inducer in treatment of acute respiratory viral infections in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Anemia in patients with chronic obstructive pulmonary disease - Association with comorbidities Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016